These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14109832)

  • 41. ROLE OF THROMBIN IN PROTHROMBIN ACTIVATION.
    SEEGERS WH; SCHROEER H; HEENE D
    Thromb Diath Haemorrh; 1964 Dec; 12():484-8. PubMed ID: 14254705
    [No Abstract]   [Full Text] [Related]  

  • 42. THE PLASMATIC ATMOSPHERE OF BLOOD PLATELETS. EVIDENCE THAT ONLY FIBRINOGEN, ACG, AND ACTIVATED HAGEMAN FACTOR ARE PRESENT ON THE SURFACE OF PLATELETS.
    IATRIDIS PG; FERGUSON JH
    Thromb Diath Haemorrh; 1965 Mar; 13():114-25. PubMed ID: 14285960
    [No Abstract]   [Full Text] [Related]  

  • 43. [Experimental studies on the problem of local Shwartzman phenomenon in the skin. V. Observations on the significance of blood coagulation disorders during provocation of the phenomenon in an endotoxin-free guinea pig model].
    Illig L; Pannen F; Winckelmann G
    Arch Dermatol Forsch; 1973 Jan; 246(1):11-26. PubMed ID: 4266409
    [No Abstract]   [Full Text] [Related]  

  • 44. IN VITRO--PRECIPITATIONS IN PLASMA BY LOW MOLECULAR WEIGHT DEXTRAN.
    KROLL J; DYBKAER R
    Scand J Clin Lab Invest; 1964; 16():31-8. PubMed ID: 14124449
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical evaluation of two tests for incipient thrombosis; prothrombin activity and fibrinogen B of Lyons.
    McCLURE RD; LAM CR
    Ann Surg; 1949 Sep; 130(3):439-47. PubMed ID: 18140187
    [No Abstract]   [Full Text] [Related]  

  • 46. [EFFECT OF DIGITALIC LOAD ON BLOOD COAGULATION, IN NORMAL SUBJECTS AND IN UNCOMPENSATED HEART DISEASE PATIENTS].
    SIDERI GC; LOCATELLI R; MORBELLI E; MASCARETTI L
    Folia Cardiol; 1964; 23():455-66. PubMed ID: 14260113
    [No Abstract]   [Full Text] [Related]  

  • 47. Continuous thrombin infusion leads to a bleeding phenotype in sheep.
    Siller-Matula JM; Miller I; Gemeiner M; Plasenzotti R; Bayer G; Mesteri I; Fabry A; Petroczi K; Nöbauer K; Razzazi-Fazeli E; Planchon S; Renaut J; Quehenberger P; Selzer E; Jilma B
    Thromb Res; 2012 Aug; 130(2):226-36. PubMed ID: 22289207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 49. Coagulation changes in isolated perfused lungs.
    Deysine M; Panossian A; Clarke RL; Cliffton EE; Veith FJ
    Vasc Dis; 1968 Jun; 5(2):70-7. PubMed ID: 5655303
    [No Abstract]   [Full Text] [Related]  

  • 50. [CHYMORAL AND COAGULATION].
    PESSEREAU G; MONTEIL R
    Rev Int Serv Sante Armees; 1963 Nov; 36():647-59. PubMed ID: 14094765
    [No Abstract]   [Full Text] [Related]  

  • 51. Influence of hydrocortisone on blood clotting and fibrinolysis after a standard resection of the liver in dogs.
    Hafström L; Lede R; Stehlin JS; Brown RO
    Surg Gynecol Obstet; 1974 Dec; 139(6):860-6. PubMed ID: 4425058
    [No Abstract]   [Full Text] [Related]  

  • 52. HAEMOSTATIC CHANGES ASSOCIATED WITH EXERCISE.
    IKKALA E; MYLLYLAE G; SARAJAS HS
    Nature; 1963 Aug; 199():459-61. PubMed ID: 14058600
    [No Abstract]   [Full Text] [Related]  

  • 53. [ANALYSIS OF BLOOD COAGULATION TIME IN EXPERIMENTAL LATHYRIC SYNDROMES].
    BELLI C; MARTINESI L
    Arch Sci Med (Torino); 1964 Dec; 118():378-86. PubMed ID: 14269264
    [No Abstract]   [Full Text] [Related]  

  • 54. [The increase of streptokinase effect by low molecular weight dextran].
    Vinazzer H; Bergmann H
    Wien Med Wochenschr; 1968 Apr; 118(15):337-40. PubMed ID: 5726102
    [No Abstract]   [Full Text] [Related]  

  • 55. LOW MOLECULAR WEIGHT DEXTRAN IN SMALL ARTERY SURGERY; ANTITHROMBOGENIC EFFECT.
    WINFREY EW; FOSTER JH
    Arch Surg; 1964 Jan; 88():78-82. PubMed ID: 14072539
    [No Abstract]   [Full Text] [Related]  

  • 56. [Activation of the fibrinolytic system by low-molecular dextran].
    Fischer M; Wimmer H
    Bibl Haematol; 1965; 23():1278-83. PubMed ID: 5885216
    [No Abstract]   [Full Text] [Related]  

  • 57. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapy with activated prothrombin complex concentrate is effective in reducing dabigatran-associated blood loss in a porcine polytrauma model.
    Honickel M; Maron B; van Ryn J; Braunschweig T; ten Cate H; Spronk HM; Rossaint R; Grottke O
    Thromb Haemost; 2016 Jan; 115(2):271-84. PubMed ID: 26333775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of prothrombin activation with dextran.
    SEEGERS WH; LEVINE WG; JOHNSON SA
    J Appl Physiol; 1955 May; 7(6):617-20. PubMed ID: 14381338
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experimental immune hemolysis and blood coagulation].
    Janzarik H; Köppler E; Lasch HG
    Thromb Diath Haemorrh; 1971 Aug; 26(1):22-8. PubMed ID: 5112375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.